Skip to main content
. 2019 Mar 6;39(10):1842–1854. doi: 10.1523/JNEUROSCI.3477-17.2018

Table 2.

Cued rGT performance during 10 d self-administration period: decision making by individual choice option at day 1 and 10 of cocaine self-administration and additional task measures at day 1 and 10 of cocaine self-administrationa

Behavioral measure Time point Cued saline optimal Cued saline risk-preferring Cued cocaine optimal Cued cocaine risk-preferring Uncued cocaine optimal
P1 Day 1 12.21 ± 9.82 4.28 ± 2.41 10.67 ± 8.93 3.98 ± 1.54 15.85 ± 4.07
P2 76.66 ± 11.58 24.89 ± 9.12 61.07 ± 9.71 15.78 ± 3.13b 73.08 ± 7.42
P3 7.99 ± 1.66 35.16 ± 11.82 11.02 ± 4.08 45.35 ± 6.15 2.37 ± 1.40
P4 3.15 ± 2.48 35.67 ± 8.89 17.23 ± 7.43 34.89 ± 6.97 8.70 ± 4.69
P1 Day 10 8.54 ± 7.50 0.89 ± 0.81 2.74 ± 1.87 3.45 ± 1.42 9.33 ± 3.94
P2 81.88 ± 9.30 24.36 ± 9.71 70.66 ± 8.62 5.66 ± 2.36b 80.71 ± 5.58
P3 7.11 ± 0.79 50.18 ± 12.96 13.69 ± 8.44 62.39 ± 7.72 2.86 ± 1.46
P4 2.47 ± 2.18 24.57 ± 7.37 13.42 ± 7.95 28.50 ± 7.18 7.09 ± 4.22
Premature responses Day 1 6.04 ± 1.48 22.82 ± 7.47 24.04 ± 5.50b 22.42 ± 4.15b 18.89 ± 2.29b
Day 10 10.18 ± 3.69 20.85 ± 5.33 5.94 ± 1.73b 16.46 ± 3.67b 14.30 ± 2.80b
Trials completed Day 1 132.20 ± 8.75 67.74 ± 10.25 93.80 ± 10.38 57.34 ± 4.92 90.45 ± 4.76b
Day 10 128.80 ± 13.07 69.60 ± 7.06 95.26 ± 13.58 53.09 ± 2.78 52.46 ± 7.21b
Omitted responses Day 1 0.40 ± 0.24 0.86 ± 0.46 0.44 ± 0.24 1.56 ± 0.72 2.82 ± 0.70
Day 10 0.20 ± 0.20 2.57 ± 1.95 2.00 ± 1.02 2.29 ± 0.75 2.22 ± 0.70
Choice latency Day 1 1.25 ± 0.30 1.93 ± 0.30 1.05 ± 0.22b 1.45 ± 0.21b 1.43 ± 0.23b
Day 10 1.74 ± 0.45 1.97 ± 0.33 1.80 ± 0.32b 1.97 ± 0.29b 2.52 ± 0.34b
Collect latency Day 1 1.04 ± 0.06 0.81 ± 0.21 0.69 ± 0.07 0.78 ± 0.11 1.18 ± 0.17
Day 10 1.03 ± 0.05 0.60 ± 0.08 0.69 ± 0.06 0.62 ± 0.06 1.25 ± 0.21

aData are mean ± SEM. We detected a significant main effect of session in P2 for cocaine risk-preferring rats (F(9,117) = 3.693, p < 0.001), which we followed up with a linear contrast (F(1,13) = 12.010, p = 0.004) to show that responding for the safe option P2 decreased in a linear fashion as cocaine self-administration progressed. No other options displayed significant within-subjects changes over session (i.e., all terms of individual repeated-measures ANOVAs were nonsignificant.

bSignificant effect across sessions as determined by post hoc tests.